Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies

Abstract

Here, Myers and Gallagher et al. characterize the structural organization of commercial influenza vaccines. The vaccines differ in their structural composition and identify a “spiked nanodisc” arrangement of hemagglutinin (HA) with increased display and immunogenicity of the conserved stem region of HA.